Skip to main content
Clinical Trials/JPRN-jRCT1031220336
JPRN-jRCT1031220336
Recruiting
Phase 2

Effects of pharmacological treatments on hemodynamics, cardiovascular reserve, exercise tolerance, and prognosis in heart failure with preserved ejection fraction - Effects of pharmacological treatments on hemodynamics, cardiovascular reserve, exercise tolerance, and prognosis in heart failure with preserved ejection fraction

Obokata Masaru0 sites125 target enrollmentSeptember 14, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Heart failure with preserved ejection fraction
Sponsor
Obokata Masaru
Enrollment
125
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Obokata Masaru

Eligibility Criteria

Inclusion Criteria

  • 1\) Age equal to or more than 20 years old
  • 2\) Patients with EF of 50% or more than 50%
  • 3\) Patients with established HFpEF or subjects who are suspected of HFpEF
  • 4\) Patients with possible new initiation of medications such as empagliflozin, sacubitril valsartan, or spironolactone.
  • 5\) Patients who give written consent to participate in this study

Exclusion Criteria

  • 1\) Patients with mimic HFpEF: Decompensated heart failure, history of EF less than 40%, pulmonary arterial hypertension, more than mild aortic or mitral valve stenosis, more than moderate aortic or mitral valve regurgitation, cardiomyopathy, acute coronary syndrome, complex adult congenital heart disease
  • 2\) Subjects who cannot keep cycle ergometry exercise (0 watts) for more than 30 seconds
  • 3\) Patients who are judged to be unsuitable for the study by the investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Effects of anti-hypertensive drug on hemodynamic changes following intraperitoneal gas insufflation for laparoscopic surgeryDiseases of the digestive system
KCT0002595Keimyung University Dongsan Medical Center50
Active, Not Recruiting
Phase 1
Pharmacological intervention of blood flow disturbances in diabetic retinal disease - Retinal blood flow and diabetesDiabetic retinal diseaseMedDRA version: 9.1Level: LLTClassification code 10012661Term: Diabetic eye disease
EUCTR2007-001697-84-DKDepartment of Ophthalmology, Aarhus University Hospital80
Not Yet Recruiting
Phase 2
Comparision of effect of cisatracurium and vecuronium (both muscle relaxant) in a patient undergoing laproscopic appendicectomy
CTRI/2019/05/019453Government medical college Bhavnagar
Active, Not Recruiting
Phase 1
Evaluation of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion at the dose of 5 mg of ivabradine given after a percutaneous coronary intervention following a myocardial infarction with ST segment elevatioAcute Myocardial InfarctionMedDRA version: 3.3Level: PTClassification code 10028596
EUCTR2005-005122-31-ESInstitut de Recherches Internationales (for France)75
Not Yet Recruiting
Phase 2
Comparison of hemodynamic and antiemetic effects of midazolam combination with three drugs , ephedrine, dexamethasone and dexmedetomidine in patients undergoing laparoscopic cholecystectomy
IRCT20141209020258N151Arak University of Medical Sciences96